Elequin Capital »

Cerevel Therapeutics Hldng I shares owned by Elequin Capital

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Elequin Capital from 13F filings

Historical chart of Elequin Capital investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Elequin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Elequin Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $424 10 42.40
2023-09-30 $349 16 21.81
2023-06-30 $13k 411 31.79
2022-12-31 $29k 922 31.54

More positions owned by Elequin Capital

Palo Alto Networks Note 0.375% 6/0 (Principal)
Aes Corp Unit 02/15/2024
Pioneer Nat Res Note 0.250% 5/1 (Principal)
United States Stl Corp Note 5.000%11/0 (Principal)
Clarivate 5.25% Pfd Conv A (CLVT.PA)
Algonquin Pwr Utils Corp Unit 06/15/2024 (AQNU)
Ugi Corp Unit 06/01/2024 (UGIC)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Conmed Corp Note 2.625% 2/0 (Principal)
Altria (MO)
Mid-America Apartment (MAA)
Proshares Tr Bitcoin Strate (BITO)
Camden Ppty Tr Sh Ben Int (CPT)
Apartment Income Reit Corp (AIRC)
Broadcom (AVGO)

View all positions for Elequin Capital

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I